News:
Moderna CEO says he'll work with Trump using 'facts and data' - The Score: Spirit, Tesla, Moderna and More Stocks That Defined the Week - Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary - Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold - Health Canada approves Moderna's mRNA RSV vaccine, company says - Health Canada approves Moderna's COVID-19 vaccine targeting latest variant - Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027 - Moderna's 'Off-the-Shelf' Cancer Vaccine Shows Promise in Early Human Trial Data - Moderna to launch skin cancer vaccine as soon as 2025: CEO
Moderna
Bookmark
ShareKey facts
- city: Cambridge
- state: MA
- country: United States
- sector: Health Care
- foundation year: 2010
- industry: Biotechnology
- CEO: Stephane Bancel
- CEO gender: Male
Classified as: organization
Summary
Moderna is a company. It is located in Cambridge, the United States and was founded in 2010. The company is part of the Health Care sector, specifically in the Biotechnology industry.
Business
Moderna is one of the companies in the United States, companies in Biotechnology, companies in Health Care and 3,466,499 companies in our database.
- Assets: 24.7B $
- Debt: 947M $
- Employees: 3,200 people
- Free cash flow: 8.6B $
- Market cap: 57.3B $
- Profits: 12.2B $
- Revenues: 22.6B $
Stocks from Moderna
Explore more on business
Talking Points:
- Pioneering mRNA technologyModerna
- Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.
- Our mission is to deliver the greatest possible impact to people through mRNA medicines.
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Learn more about talking points